Evrys Bio

About:

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

Website: https://evrys.com/

Top Investors: Keiretsu Capital, Mid Atlantic Bio Angels, ShangPharma Innovation, Defense Threat Reduction Agency (DTRA)

Description:

Evrys Bio was founded on breakthrough discoveries made at Princeton University. Whereas immuno-oncology drugs engage the patient’s immune system to fight cancer, Evrys Bio antivirals engage the cell’s intrinsic immunity to defend against infection. Evrys Bio’s vision is to develop first-in-class antivirals that are safe, address the problem of acquired drug-resistance, and provide unique broad-spectrum treatment options. This will transform the practice of medicine by addressing the infectious disease condition holistically as opposed to targeting a specific virus-type.